Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2013

CollabRX, Inc. (CLRX) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 9, 2013 by Mission IR

CollabRX is a leader in cloud-based expert systems for informing healthcare decision-making. Beginning with the area of greatest need, which is advanced cancer in patients who have effectively exhausted the standard of care, the company uses information technology to aggregate … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Atossa Genetics Inc. (ATOS) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

Atossa Genetics is a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast Health Test; and the ArgusCYTE … Continue reading →

Posted in EBD Group Conference | Leave a comment

Response Biomedical Corp. (RPBIF) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 9, 2013 by Mission IR

Response Biomedical is a developer, manufacturer and marketer of rapid onsite diagnostics tests for use with its RAMP platform for clinical and environmental applications. Representing a new paradigm in diagnostics, RAMP provides reliable laboratory-quality results in minutes and is ideally … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Oxygen Biotherapeutics, Inc. (OXBT) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 9, 2013 by Mission IR

Oxygen Biotherapeutics is a development stage biomedical company engaged in the development of oxygen-rich intravenous and topical products. Oxycyte, the company’s proprietary perfluorocarbon (PFC) therapeutic oxygen carrier, is currently in clinical and preclinical studies for intravenous delivery for various indications. … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Repros Therapeutics Inc. (RPRX) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

Repros Therapeutics is a development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health. The company’s current product pipeline includes Androxal®, in phase 2 trials for male … Continue reading →

Posted in EBD Group Conference | Leave a comment

Pressure BioSciences Inc. (PBIO) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

Pressure BioSciences engages in the development and commercialization of pressure cycling technology (PCT), a patented, enabling technology platform with multiple applications in the life sciences sample preparation market. PBIO’s focus is on the development and sale of PCT-enhanced sample preparation … Continue reading →

Posted in EBD Group Conference | Leave a comment

Synthetic Biologics, Inc. (SYN) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 9, 2013 by Mission IR

Synthetic Biologics is a biotechnology company developing product candidates for serious infections and diseases. The company is developing a biologic for preventing C. diff infection as well as a series of monoclonal antibodies (mAbs) for treating serious infectious diseases. In … Continue reading →

Posted in OneMedForum Conference | Leave a comment

NeoStem, Inc. (NBS) Announces Presentation of Published Research Supporting VSEL Technology at the ASH Annual Meeting

Posted on January 9, 2013 by MissionIR

NeoStem, an emerging leader in the fast growing cell therapy market, announced the publication of papers as 2012 Annual Meeting Abstracts in the journal Blood, Volume 120, Issue 21. These publications were presented as abstracts on December 8-11 at the … Continue reading →

Posted in Small Cap News | Leave a comment

Amarantus Bioscience Inc. (AMBS) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

Amarantus Bioscience is a development-stage biotech company focused on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI) and other human diseases. The company owns the intellectual property rights to … Continue reading →

Posted in EBD Group Conference | Leave a comment

Amtech Systems, Inc. (ASYS) Announces Subsidiary Recipient of Cleantech Award

Posted on January 9, 2013 by MissionIR

Amtech Systems announced that the company’s subsidiary, Tempress Systems BV was awarded with the WNF Cleantech Star 2012, an award sponsored by the World Wide Fund for Nature The Netherlands in Rotterdam. Tempress was awarded the Cleantech award by Ab … Continue reading →

Posted in Small Cap News | Leave a comment